Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gibson

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Annals of Neurology|February 2, 2006
UCHL-1 is not a Parkinson's disease susceptibility geneDaniel G Healy, Patrick M Abou-Sleiman, Juan P Casas, et al.
American Journal of Human Genetics|May 11, 2006
Genomewide association, Parkinson disease, and PARK10Matthew J Farrer, Kristoffer Haugarvoll, Owen A Ross, et al.
Lancet (London, England)|February 2, 2010
A framework for mandatory impact evaluation to ensure well informed public policy decisionsAndrew D Oxman, Arild Bjørndal, Francisco Becerra-Posada, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2009
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expressionChristian Wider, Justus C Dachsel, Alexandra I Soto, et al.
Communications Biology|January 11, 2024
Detection of chromosomal aneuploidy in ancient genomesKyriaki Anastasiadou, Marina Silva, Thomas Booth, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Human Genetics : EJHG|October 16, 2008
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll, Mathias Toft, Lisa Skipper, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Annals of Neurology|February 2, 2006
UCHL-1 is not a Parkinson's disease susceptibility geneDaniel G Healy, Patrick M Abou-Sleiman, Juan P Casas, et al.
American Journal of Human Genetics|May 11, 2006
Genomewide association, Parkinson disease, and PARK10Matthew J Farrer, Kristoffer Haugarvoll, Owen A Ross, et al.
Lancet (London, England)|February 2, 2010
A framework for mandatory impact evaluation to ensure well informed public policy decisionsAndrew D Oxman, Arild Bjørndal, Francisco Becerra-Posada, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2009
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expressionChristian Wider, Justus C Dachsel, Alexandra I Soto, et al.
Communications Biology|January 11, 2024
Detection of chromosomal aneuploidy in ancient genomesKyriaki Anastasiadou, Marina Silva, Thomas Booth, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Pageof 13